Literature DB >> 25685044

The effect of antifungal combination on transcripts of a subset of drug-resistance genes in clinical isolates of Candida species induced biofilms.

Nermin H Ibrahim1, Nahla A Melake2, Ali M Somily3, Azza S Zakaria4, Manal M Baddour5, Amany Z Mahmoud6.   

Abstract

Biofilm formation is often associated with increased Candida resistance toward antifungal agents. Therefore, the current study aimed to assess the incidence of biofilm formation among Candida isolates and to investigate the effect of high doses of fluconazole {FLC}, voriconazole {VOC} and amphotericin B {AMB}, singly and in combination on mature biofilms. Moreover, it aimed to assess the expression of selected genes (CDR1, KRE1 and SKN1) responsible for Candida biofilm resistance. The study included 49 patients; samples were collected from the King Khalid Hospital, Riyadh, Saudi Arabia. Isolates were prepared for biofilm formation and quantification using 0.4% (w/v) crystal violet. Minimum Inhibitory concentration (MIC) and fractional inhibitory concentration (FIC) were conducted by the broth microdilution method. Biofilm eradication was evaluated using counting, XTT stain intensity and observed under the inverted microscope. Selected genes were evaluated in Candida biofilms under the effect of antifungal exposure using QPCR. The major isolates were Candida albicans (65.3%) followed by Candida tropicalis and Candida glabrata. 77.6% of the strains were biofilm formers. AMB showed susceptibility in 87.8% of isolates, followed by VOC (77.6%) and FLC (67.3%). MIC50 and MIC90 were (0.03, 0.125), (0.5, 8), (2, >128) μg/ml for AMB, VOC and FLC, respectively. 34.7% and 18.4% of the isolates were antagonistic to AMB/FLC and AMB/VOC, respectively. Mature biofilms of ten selected isolates were found resistant to FLC (1000 μg/ml). VOR and AMB concentration required to inhibit biofilm formation was 16-250 fold higher than the MIC for planktonic cells. Isolates showed significant reduction with antifungal combination when compared with the untreated controls (p value ⩽ 0.01), or using fluconazole alone (p value ⩽ 0.05). High doses of the antifungals were employed to assess the effect on the persisters' selected gene expression. Marked over expression of SKN1 and to a lesser extent KRE1 was noticed among the mature biofilms treated with AMB alone or in combination after 1 h of exposure, and SKN1 expression was even more sharply induced after 24 h. No statistically significant over expression of CDR1 was observed in biofilms after exposure to high doses of FLC, VOC or any of the combinations used.

Entities:  

Keywords:  Antifungal; Biofilm; CDR1; Candida spp.; KRE1; SKN1

Year:  2013        PMID: 25685044      PMCID: PMC4310964          DOI: 10.1016/j.jsps.2013.12.007

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  61 in total

Review 1.  Nature and development of phenotypic resistance to amphotericin B in Candida albicans.

Authors:  E F Gale
Journal:  Adv Microb Physiol       Date:  1986       Impact factor: 3.517

2.  Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.

Authors:  Eiman M Mokaddas; Noura A Al-Sweih; Zia U Khan
Journal:  J Med Microbiol       Date:  2007-02       Impact factor: 2.472

3.  Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement.

Authors:  I Raad; W Costerton; U Sabharwal; M Sacilowski; E Anaissie; G P Bodey
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

Review 4.  Molecular genetic analysis of azole antifungal mode of action.

Authors:  S L Kelly; A Arnoldi; D E Kelly
Journal:  Biochem Soc Trans       Date:  1993-11       Impact factor: 5.407

5.  A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes.

Authors:  Prasanna D Khot; Peter A Suci; R Lance Miller; Raoul D Nelson; Bonnie J Tyler
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

6.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

7.  Isolation of the Candida albicans homologs of Saccharomyces cerevisiae KRE6 and SKN1: expression and physiological function.

Authors:  T Mio; T Yamada-Okabe; T Yabe; T Nakajima; M Arisawa; H Yamada-Okabe
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

8.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

9.  Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.

Authors:  Pranab K Mukherjee; Jyotsna Chandra; Duncan M Kuhn; Mahmoud A Ghannoum
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  6 in total

1.  Virulence Factors and Antifungal Susceptibility Profile of C. tropicalis Isolated from Various Clinical Specimens in Alexandria, Egypt.

Authors:  Mohammed A El-Kholy; Ghada F Helaly; Ebtisam F El Ghazzawi; Gamal El-Sawaf; Sherine M Shawky
Journal:  J Fungi (Basel)       Date:  2021-04-29

2.  In vitro antifungal activity of organic compounds derived from amino alcohols against onychomycosis.

Authors:  César Augusto Caneschi; Angelina Maria de Almeida; Francislene Juliana Martins; Mireille Le Hyaric; Manoel Marques Evangelista Oliveira; Gilson Costa Macedo; Mauro Vieira de Almeida; Nádia Rezende Barbosa Raposo
Journal:  Braz J Microbiol       Date:  2017-02-09       Impact factor: 2.476

3.  Antifungal Action of Methylene Blue Involves Mitochondrial Dysfunction and Disruption of Redox and Membrane Homeostasis in C. albicans.

Authors:  Moiz A Ansari; Zeeshan Fatima; Saif Hameed
Journal:  Open Microbiol J       Date:  2016-02-25

4.  Voriconazole treatment of Candida tropicalis meningitis: persistence of (1,3)-β-D-glucan in the cerebrospinal fluid is a marker of clinical and microbiological failure: A case report.

Authors:  Giancarlo Ceccarelli; Maria Cristina Ghezzi; Giammarco Raponi; Grazia Brunetti; Carolina Marsiglia; Stefania Fallani; Andrea Novelli; Mario Venditti
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

5.  Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp.

Authors:  Célia F Rodrigues; Mariana Henriques
Journal:  Pathogens       Date:  2017-12-01

Review 6.  Candida glabrata Biofilms: How Far Have We Come?

Authors:  Célia F Rodrigues; Maria Elisa Rodrigues; Sónia Silva; Mariana Henriques
Journal:  J Fungi (Basel)       Date:  2017-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.